Cell-permeable reprogramming factor (iCP-RF) recombinant protein and use thereof

1. A recombinant protein, which comprises a RF protein selected from the group consisting of OCT4, SOX2, CMYC, KLF4, NANOG, LIN28 and ZSCAN4, and an advanced macromolecule transduction domain (aMTD) being composed of 12 amino acid residues and having improved cell or tissue permeability,

wherein the aMTD has an amino acid sequence selected from the group consisting of SEQ ID NOs: 39, 43, 84, 96, 131, 223, 226, and 233, or the aMTD is encoded by a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 279, 283, 324, 336 371, 463, 466, and 473.

2. The recombinant protein according to claim 1 , wherein one or more solubilization domain (SD)(s) are further fused to the end(s) of one or more of the RF protein and the aMTD, wherein the one or more SD(s) independently have an amino acid sequence selected from the group consisting of SEQ ID NOs: 798-804.

3. The recombinant protein according to claim 2 , wherein the recombinant protein is represented by any one of the following structural formula:

A-B—C and A-C—B—C

wherein A is an advanced macromolecule transduction domain (aMTD) having improved cell or tissue permeability, B is a RF protein selected from the group consisting of OCT4, SOX2, CMYC, KLF4, NANOG, LIN28 and ZSCAN4, and C is a solubilization domain (SD); and wherein one or more SD(s) independently have an amino acid sequence selected from the group consisting of SEQ ID NOs: 798-804.

4. The recombinant protein according to claim 1 , wherein the RF protein has an amino acid sequence selected from the group consisting of SEQ ID NOs: 816 to 822.

5. The recombinant protein according to claim 4 , wherein the RF protein is encoded by a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 823 to 829.

6. The recombinant protein of claim 2 , wherein the SD(s), independently, are encoded by a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 805 to 811.

7. The recombinant protein according to claim 1 , wherein the fusion is formed via a peptide bond or a chemical bond.

8. The recombinant protein according to claim 1 , wherein the recombinant protein is used for the generation of induced pluripotent stem cells (iPSCs) from somatic cells.

9. A preparing method of the recombinant protein of claim 1 comprising:

culturing a transformant comprising an exogenous polynucleotide encoding the recombinant protein of claim 1 in a culture medium to produce the recombinant protein; and

recovering the recombinant protein expressed by the culturing.

10. A method of inducing generation of iPSCs from somatic cells comprising:

treating the somatic cells with an effective amount of the recombinant protein according to claim 1 .

11. The recombinant protein of claim 3 , wherein the SD(s), independently, are encoded by a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 805 to 811.

12. A preparing method of the recombinant protein comprising:

culturing a transformant comprising a n exogenous polynucleotide encoding the recombinant protein of claim 3 in a culture medium to produce the recombinant protein; and

recovering the recombinant protein expressed by the culturing.

13. The method according to claim 9 , wherein the polynucleotide sequence is selected from the group consisting of SEQ ID NOs: 831, 837, 843, 849, 855, 861, and 867.

14. The method according to claim 12 , wherein the polynucleotide sequence is selected from the group consisting of SEQ ID NOs: 833, 839, 845, 851, 857, 863, and 869.